The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Mechanisms regulating glioma invasion
Open accessAbstract
Glioblastoma (GBM) is the most aggressive, deadliest, and most common brain malignancy in adults. Despite the advances made in surgical techniques, radiotherapy and chemotherapy, the median survival for GBM patients has remained at a mere 14 months. GBM poses several unique challenges to currently available treatments for the disease. For example, GBM cells have the propensity to aggressively infiltrate/invade into the normal brain tissues and along the vascular tracks, which prevents complete resection of all malignant cells and limits the effect of localized radiotherapy while sparing normal tissue. Although anti-angiogenic treatment exerts anti-edematic effect in GBM, unfortunately, tumors progress with acquired increased invasiveness. Therefore, it is an important task to gain a deeper understanding of the intrinsic and post-treatment invasive phenotypes of GBM in hopes that the gained knowledge would lead to novel GBM treatments that are more effective and less toxic. This review will give an overview of some of the signaling pathways that have been shown to positively and negatively regulate GBM invasion, including, the PI3K/Akt, Wnt, sonic hedgehog-GLI1, and microRNAs. The review will also discuss several approaches to cancer therapies potentially altering GBM invasiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Koul, D., Parthasarathy, R. V., Shen, R., Davies, M. A., Jasser, S. A., Chintala, S. K., Rao, J. S., Sun, Y., Benvenisite, E. N., Liu, T.-J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204799 · Cited by 115
RetractedRadiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro, A. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,301
Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
A neurocentric perspective on glioma invasion
Cuddapah, V. A., Robel, S., Watkins, S., & Sontheimer, H. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3765 · Cited by 831
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Wnt and calcium signaling: β-Catenin-independent pathways
Kohn, A. D., & Moon, R. T. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.022 · Cited by 730
Glioblastoma survival in the United States before and during the temozolomide era
Johnson, D. R., & O’Neill, B. P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0749-4 · Cited by 720
Identification of an Amplified, Highly Expressed Gene in a Human Glioma
Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., & Vogelstein, B. (1987) · Science · doi:10.1126/science.3563490 · Cited by 681
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Cohen, M. H., Shen, Y. L., Keegan, P., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0121 · Cited by 655
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Pola, R., Ling, L. E., Silver, M., Corbley, M. J., Kearney, M., Blake Pepinsky, R., Shapiro, R., Taylor, F. R., Baker, D. P., Asahara, T., et al. (2001) · Nature Medicine · doi:10.1038/89083 · Cited by 612
van den Bent, M. J., Brandes, A. A., Rampling, R., Kouwenhoven, M. C. M., Kros, J. M., Carpentier, A. F., Clement, P. M., Frenay, M., Campone, M., Baurain, J.-F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5984 · Cited by 575
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Molecular Mechanisms of Glioma Cell Migration and Invasion
Demuth, T., & Berens, M. E. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-2751-6 · Cited by 544
Emerging treatment strategies for glioblastoma multiforme
Carlsson, S. K., Brothers, S. P., & Wahlestedt, C. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302627 · Cited by 365
Yoon, J. W., Kita, Y., Frank, D. J., Majewski, R. R., Konicek, B. A., Nobrega, M. A., Jacob, H., Walterhouse, D., & Iannaccone, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105708200 · Cited by 334
Recurrent glioblastoma multiforme: a review of natural history and management options
Hou, L. C., Veeravagu, A., Hsu, A. R., & Tse, V. C. K. (2006) · Neurosurgical Focus · doi:10.3171/foc.2006.20.4.2 · Cited by 275
Ji, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., Litchfield, D. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.034 · Cited by 270
Targeting adaptive glioblastoma: an overview of proliferation and invasion
Xie, Q., Mittal, S., & Berens, M. E. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou147 · Cited by 262
Transcriptional Regulation of bcl-2 Mediated by the Sonic Hedgehog Signaling Pathway through gli-1
Bigelow, R. L. H., Chari, N. S., Undén, A. B., Spurgers, K. B., Lee, S., Roop, D. R., Toftgård, R., & McDonnell, T. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310589200 · Cited by 248
Smits, M., Nilsson, J., Mir, S. E., van der Stoop, P. M., Hulleman, E., Niers, J. M., de Witt Hamer, P. C., Marquez, V. E., Cloos, J., Krichevsky, A. M., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.205 · Cited by 236
Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
Pu, P., Zhang, Z., Kang, C., Jiang, R., Jia, Z., Wang, G., & Jiang, H. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2008.78 · Cited by 231
International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors
Schulte, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002931 · Cited by 231
Tu, Y., Gao, X., Li, G., Fu, H., Cui, D., Liu, H., Jin, W., & Zhang, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0358 · Cited by 209
Sonic hedgehog signalling pathway: a complex network
Choudhry, Z., Rikani, A. A., Choudhry, A. M., Tariq, S., Zakaria, F., Asghar, M. W., Sarfraz, M. K., Haider, K., Shafiq, A. A., & Mobassarah, N. J. (2014) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.210109 · Cited by 208
Cathepsins mediate tumor metastasis
Tan, G.-J., Peng, Z.-K., Lu, J.-P., & Tang, F.-Q. (2013) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v4.i4.91 · Cited by 201
A role of PDGFRα in basal cell carcinoma proliferation
Xie, J., Aszterbaum, M., Zhang, X., Bonifas, J. M., Zachary, C., Epstein, E., & McCormick, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151173398 · Cited by 192
Dijksterhuis, J. P., Petersen, J., & Schulte, G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12364 · Cited by 182
Koul, D., Fu, J., Shen, R., LaFortune, T. A., Wang, S., Tiao, N., Kim, Y.-W., Liu, J.-L., Ramnarian, D., Yuan, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1558 · Cited by 171
Emerging Therapies for Glioblastoma
Thomas, A. A., Brennan, C. W., DeAngelis, L. M., & Omuro, A. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1701 · Cited by 167
Prasad, G., Sottero, T. L., Yang, X., Mueller, S., James, C. D., Weiss, W. A., Polley, M. Y., Ozawa, T., Berger, M. S., Aftab, D. T., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq193 · Cited by 165
Agarwal, S., Manchanda, P., Vogelbaum, M. A., Ohlfest, J. R., & Elmquist, W. F. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048322 · Cited by 163
Filbin, M. G., Dabral, S. K., Pazyra‐Murphy, M. F., Ramkissoon, S. H., Kung, A. L., Pak, E., Chung, J. Y., Theisen, M., Sun, Y., Franchetti, Y., et al. (2013) · Nature Medicine · doi:10.1038/nm.3328 · Cited by 162
A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
Lo, H., Zhu, H., Cao, X., Aldrich, A. J., & Ali‐Osman, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0886 · Cited by 153
Self-citationSami, A., & Karsy, M. J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0800-5 · Cited by 151
Current clinical development of PI3K pathway inhibitors in glioblastoma
Wen, P. Y., Lee, E. Q., Reardon, D. A., Ligon, K. L., & Yung, W. K. A. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos117 · Cited by 144
MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation
Shi, L., Zhang, J., Pan, T., Zhou, J., Gong, W., Liu, N., Fu, Z., & You, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.056 · Cited by 138
miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β
Song, L., Huang, Q., Chen, K., Liu, L., Lin, C., Dai, T., Yu, C., Wu, Z., & Li, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.003 · Cited by 138
Shi, L. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1179 · Cited by 135
Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma
Kaur, N., Chettiar, S. T., Rathod, S. S., Rath, P., Muzumdar, D., Shaikh, M. L., & Shiras, A. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.001 · Cited by 133
Kamino, M., Kishida, M., Kibe, T., Ikoma, K., Iijima, M., Hirano, H., Tokudome, M., Chen, L., Koriyama, C., Yamada, K., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01815.x · Cited by 132
Cao, X., Geradts, J., Dewhirst, M. W., & Lo, H. (2011) · Oncogene · doi:10.1038/onc.2011.219 · Cited by 129
Self-citationWnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
Kim, K. H., Seol, H. J., Kim, E. H., Rheey, J., Jin, H. J., Lee, Y., Joo, K. M., Lee, J., & Nam, D. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos299 · Cited by 127
Kubiatowski, T., Jang, T., Lachyankar, M. B., Salmonsen, R. A., Nabi, R. R., Quesenberry, P. J., Litofsky, N. S., Ross, A. H., & Recht, L. D. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.3.0480 · Cited by 115
Fu, J., Rodova, M., Nanta, R., Meeker, D., Veldhuizen, P. J. V., Srivastava, R. K., & Shankar, S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not011 · Cited by 112
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III
Visani, M., de Biase, D., Marucci, G., Cerasoli, S., Nigrisoli, E., Reggiani, M. L. B., Albani, F., Baruzzi, A., Pession, A., & the PERNO study group (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.010 · Cited by 108
β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells
Nàger, M., Bhardwaj, D., Cantí, C., Medina, L. M., Nogués, P., & Herreros, J. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/192362 · Cited by 107
Liu, Y., Yan, W., Zhang, W., Chen, L., You, G., Bao, Z., Wang, Y., Wang, H., Kang, C., & Jiang, T. (2012) · Oncology Reports · doi:10.3892/or.2012.1902 · Cited by 106
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
Li, X., Liu, Y., Granberg, K. J., Wang, Q., Moore, L. M., Ji, P., Gumin, J., Sulman, E. P., Calin, G. A., Haapasalo, H., et al. (2015) · Oncogene · doi:10.1038/onc.2014.98 · Cited by 99
Mazar, A. P., Ahn, R. W., & O’Halloran, T. V. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796718152 · Cited by 84
Zhu, H., & Lo, H. (2010) · Current Genomics · doi:10.2174/138920210791233108 · Cited by 83
Self-citationDikshit, B., Irshad, K., Madan, E., Aggarwal, N., Sarkar, C., Chandra, P. S., Gupta, D. K., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2012) · Oncogene · doi:10.1038/onc.2012.393 · Cited by 80
Shapiro, L., Beal, K. P., Goenka, A., Karimi, S., IWAMOTO, F. M., Yamada, Y. J., Zhang, Z., Lassman, A. B., Abrey, L. E., & Gutin, P. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.031 · Cited by 67
Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway
Jiang, L., Wu, J., Yang, Y., Liu, L., Song, L., Li, J., & Li, M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-406 · Cited by 67
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Zhu, H., Carpenter, R. L., Han, W., & Lo, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.014 · Cited by 64
Self-citationGlioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy
Biasoli, D., Sobrinho, M., da Fonseca, A. C. C., de Matos, D. G., Romão, L. F., Maciel, R. D. M., Rehen, S. K., Moura‐Neto, V., Borges, H. L., & Lima, F. R. S. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.36 · Cited by 55
Gao, X., Mi, Y., Ma, Y., & Jin, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2466-z · Cited by 55
miR‐101 Acts as a Tumor Suppressor by Targeting Kruppel‐like Factor 6 in Glioblastoma Stem Cells
Yao, Y., Ma, J., Wang, P., Xue, Y., Li, Z., Zhao, L., Li, Z., Feng, T., & Liu, Y. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12321 · Cited by 53
Lee, H., Park, I., Park, K. H., An, S., Woo, S., Jin, H., Chung, H. Y., Lee, S., Gwak, H., Hong, Y., et al. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20312 · Cited by 52
Robertis, A. D., Valensin, S., Rossi, M., Tunici, P., Verani, M., Rosa, A. D., Giordano, C., Varrone, M., Nencini, A., Pratelli, C., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1176-t · Cited by 52
Mehran, R. J., Nilsson, M. B., Khajavi, M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2044 · Cited by 51
Grimm, S. A., Marymont, M. H., Chandler, J. P., Muro, K., Newman, S. B., Levy, R. M., Jovanovic, B., McCarthy, K., & Raizer, J. J. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0957-6 · Cited by 50
The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness
Gao, X., & Jin, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.011 · Cited by 50
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
Cohen, K. J., Gibbs, I. C., Fisher, P. G., Hayashi, R. J., Macy, M. E., & Gore, L. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not021 · Cited by 48
Hedgehog signaling pathway: Development of antagonists for cancer therapy
Xie, J. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0018-7 · Cited by 47
Mechanisms of glioma cell invasion
Tonn, J. C., & Goldbrunner, R. (2003) · Springer eBooks · doi:10.1007/978-3-7091-6090-9_22 · Cited by 43
Shi, L., Wan, Y., Sun, G., Zhang, S., Wang, Z., & Zeng, Y. (2013) · BioDrugs · doi:10.1007/s40259-013-0053-2 · Cited by 42
Ephs and Ephrins in malignant gliomas
Ferluga, S., & Debinski, W. (2014) · Growth Factors · doi:10.3109/08977194.2014.985787 · Cited by 30
Self-citationCarpenter, R. L., & Lo, H. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394622-5.00006-7 · Cited by 28
Self-citationRegulation and dysregulation of astrocyte activation and implications in tumor formation
Yang, C., Rahimpour, S., Yu, A. C., Lonser, R. R., & Zhuang, Z. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1274-8 · Cited by 27
Guo, G., Kuai, D., Cai, S., Xue, N., Liu, Y., Hao, J.-H., Fan, Y., Ji, J., Mao, X., Liu, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061206 · Cited by 26
Hara, K., Kageji, T., Mizobuchi, Y., Kitazato, K. T., Okazaki, T., Fujihara, T., Nakajima, K., Mure, H., Kuwayama, K., Hara, T., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.045 · Cited by 23
Gwak, H., Park, M., Park, I., Woo, S. H., Jin, H., Rhee, C. H., & Jung, H. (2014) · Journal of neurosurgery · doi:10.3171/2014.8.jns131991 · Cited by 19
Peng, B., Li, D., Qin, M., Luo, D., Zhang, X., Zhao, H., & Hu, S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1507-3 · Cited by 16
Cited by
Identification of diverse astrocyte populations and their malignant analogs
John Lin, C.-C., Yu, K., Hatcher, A., Huang, T.-W., Lee, H. K., Carlson, J., Weston, M. C., Chen, F., Zhang, Y., Zhu, W., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4493 · Cited by 525
Emerging therapies for glioblastoma: current state and future directions
Rong, L., Li, N., & Zhang, Z. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02349-7 · Cited by 510
Genetically engineered cerebral organoids model brain tumor formation
Bian, S., Repic, M., Guo, Z., Kavirayani, A., Burkard, T., Bagley, J. A., Krauditsch, C., & Knoblich, J. A. (2018) · Nature Methods · doi:10.1038/s41592-018-0070-7 · Cited by 415
Verdugo, E., Puerto, I., & Medina, M. Á. (2022) · Cancer Communications · doi:10.1002/cac2.12361 · Cited by 253
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
Yi, Y., Hsieh, I.-Y., Huang, X., Li, J., & Zhao, W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00477 · Cited by 105
Metadata
- Authors
- Paw, I., Carpenter, R. C., Watabe, K., Debinski, W., & Lo, H.-W.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 362
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2034437737
- Cited by
- 306
- References
- 82
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.